论文与基金

订阅

MedSci主页 / 所有栏目 / 论文与基金

Scientific Reports的MedSci指数跃居**，成为热门的期刊之首

2016-07-25 MedSci MedSci原创

MedSci指数ScientificReports
关注

MedSci指数是期刊发展，以及用户喜好度的重要风向标。在此前MedSci指数排名第一的是PLOS ONE，最高峰达到463！但此后一直下降，2016年到现在的实时指数仅为415.7，下降十分明显。 然而，Scientific Reports后来居上，2016年实时指数为453.4！目前居所有期刊第一位，以此速度，预计到年底，其指数有望突破463这个极值。

MedSci指数是期刊发展，以及用户喜好度的重要风向标。在此前MedSci指数排名第一的是PLOS ONE，最高峰达到463！但此后一直下降，2016年到现在的实时指数仅为415.7，下降十分明显。



然而，Scientific Reports后来居上，2016年实时指数为453.4！目前居所有期刊第一位，以此速度，预计到年底，其指数有望突破463这个极值。



不管怎么说，这两本期刊是OA的重要代表，虽然OA的经营模式备受非议，但是OA的快速发展，令传统期刊巨头也不得不转型，或探索OA的模式。

从另一角度上看，OA期刊在中国有如此大的关注度，也表明市场巨大！中国科研实力的快速提升，从一定程度上也给OA期刊加了一把火。

MedSci指数包括“MedSci五年指数”、“MedSci年度指数”和“MedSci实时指数”，能全面反映期刊的用户关注度，对于指导期刊的发展具有十分重要的价值。同样，对于用户的投稿期刊选择来说，同样是重要的参数和指标。

了解更多，请下载梅斯医学APP！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1375296, encodeId=6be313e5296aa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464229, encodeId=ca611464229d6, content=<a href='/topic/show?id=d7fb1150293' target=_blank style='color:#2F92EE;'>#MedSci指数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11502, encryptionId=d7fb1150293, topicName=MedSci指数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=758f6619278, createdName=soongzhihua, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607001, encodeId=61e2160e00131, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94744, encodeId=8dde94e4479, content=国人吹嘘为nature子刊，显然关注度高, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06bb18292, createdName=endlesskevin, createdTime=Tue Jul 26 17:23:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94718, encodeId=1dd494e1877, content=江山代有才人出，一代新人换旧人, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Tue Jul 26 08:41:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94653, encodeId=c8829465301, content=可以考虑！, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 21:41:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94647, encodeId=dbe19464e1b, content=一目了然！, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Jul 25 21:35:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-27 jichang

    #SCIE#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1375296, encodeId=6be313e5296aa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464229, encodeId=ca611464229d6, content=<a href='/topic/show?id=d7fb1150293' target=_blank style='color:#2F92EE;'>#MedSci指数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11502, encryptionId=d7fb1150293, topicName=MedSci指数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=758f6619278, createdName=soongzhihua, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607001, encodeId=61e2160e00131, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94744, encodeId=8dde94e4479, content=国人吹嘘为nature子刊，显然关注度高, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06bb18292, createdName=endlesskevin, createdTime=Tue Jul 26 17:23:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94718, encodeId=1dd494e1877, content=江山代有才人出，一代新人换旧人, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Tue Jul 26 08:41:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94653, encodeId=c8829465301, content=可以考虑！, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 21:41:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94647, encodeId=dbe19464e1b, content=一目了然！, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Jul 25 21:35:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-27 soongzhihua

    #MedSci指数#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1375296, encodeId=6be313e5296aa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464229, encodeId=ca611464229d6, content=<a href='/topic/show?id=d7fb1150293' target=_blank style='color:#2F92EE;'>#MedSci指数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11502, encryptionId=d7fb1150293, topicName=MedSci指数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=758f6619278, createdName=soongzhihua, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607001, encodeId=61e2160e00131, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94744, encodeId=8dde94e4479, content=国人吹嘘为nature子刊，显然关注度高, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06bb18292, createdName=endlesskevin, createdTime=Tue Jul 26 17:23:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94718, encodeId=1dd494e1877, content=江山代有才人出，一代新人换旧人, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Tue Jul 26 08:41:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94653, encodeId=c8829465301, content=可以考虑！, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 21:41:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94647, encodeId=dbe19464e1b, content=一目了然！, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Jul 25 21:35:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-27 ms3994565386320060

    #Med#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1375296, encodeId=6be313e5296aa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464229, encodeId=ca611464229d6, content=<a href='/topic/show?id=d7fb1150293' target=_blank style='color:#2F92EE;'>#MedSci指数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11502, encryptionId=d7fb1150293, topicName=MedSci指数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=758f6619278, createdName=soongzhihua, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607001, encodeId=61e2160e00131, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94744, encodeId=8dde94e4479, content=国人吹嘘为nature子刊，显然关注度高, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06bb18292, createdName=endlesskevin, createdTime=Tue Jul 26 17:23:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94718, encodeId=1dd494e1877, content=江山代有才人出，一代新人换旧人, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Tue Jul 26 08:41:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94653, encodeId=c8829465301, content=可以考虑！, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 21:41:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94647, encodeId=dbe19464e1b, content=一目了然！, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Jul 25 21:35:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-26 endlesskevin

    国人吹嘘为nature子刊，显然关注度高

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1375296, encodeId=6be313e5296aa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464229, encodeId=ca611464229d6, content=<a href='/topic/show?id=d7fb1150293' target=_blank style='color:#2F92EE;'>#MedSci指数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11502, encryptionId=d7fb1150293, topicName=MedSci指数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=758f6619278, createdName=soongzhihua, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607001, encodeId=61e2160e00131, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94744, encodeId=8dde94e4479, content=国人吹嘘为nature子刊，显然关注度高, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06bb18292, createdName=endlesskevin, createdTime=Tue Jul 26 17:23:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94718, encodeId=1dd494e1877, content=江山代有才人出，一代新人换旧人, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Tue Jul 26 08:41:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94653, encodeId=c8829465301, content=可以考虑！, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 21:41:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94647, encodeId=dbe19464e1b, content=一目了然！, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Jul 25 21:35:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-26 huangwukui

    江山代有才人出，一代新人换旧人

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1375296, encodeId=6be313e5296aa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464229, encodeId=ca611464229d6, content=<a href='/topic/show?id=d7fb1150293' target=_blank style='color:#2F92EE;'>#MedSci指数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11502, encryptionId=d7fb1150293, topicName=MedSci指数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=758f6619278, createdName=soongzhihua, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607001, encodeId=61e2160e00131, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94744, encodeId=8dde94e4479, content=国人吹嘘为nature子刊，显然关注度高, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06bb18292, createdName=endlesskevin, createdTime=Tue Jul 26 17:23:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94718, encodeId=1dd494e1877, content=江山代有才人出，一代新人换旧人, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Tue Jul 26 08:41:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94653, encodeId=c8829465301, content=可以考虑！, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 21:41:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94647, encodeId=dbe19464e1b, content=一目了然！, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Jul 25 21:35:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-25 1dd8c52fm63(暂无匿称)

    可以考虑！

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1375296, encodeId=6be313e5296aa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464229, encodeId=ca611464229d6, content=<a href='/topic/show?id=d7fb1150293' target=_blank style='color:#2F92EE;'>#MedSci指数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11502, encryptionId=d7fb1150293, topicName=MedSci指数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=758f6619278, createdName=soongzhihua, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607001, encodeId=61e2160e00131, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jul 27 11:33:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94744, encodeId=8dde94e4479, content=国人吹嘘为nature子刊，显然关注度高, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06bb18292, createdName=endlesskevin, createdTime=Tue Jul 26 17:23:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94718, encodeId=1dd494e1877, content=江山代有才人出，一代新人换旧人, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Tue Jul 26 08:41:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94653, encodeId=c8829465301, content=可以考虑！, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 21:41:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94647, encodeId=dbe19464e1b, content=一目了然！, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Jul 25 21:35:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-25 lovetcm

    一目了然！

    0

相关资讯

MedSci年度指数和5年指数正式上线

MedSci指数自从2009年12月推出以来(MedSci面向大中华区用户首推MedSci指数)，得到广大用户的重视与喜爱，它作为独立于影响因子之外的重要指标之一，可以认为是期刊选择的重要风向标(MedSci指数应用技巧：与影响因子配合使用)。 自从推出MedSci指数以来，一直关注各个期刊的指数变化趋势与特征，也为期刊发展提供重要的参考，同时也不断优化算法，以期更准确反映用户的行为

提高SCI期刊论文收录率的技巧与方法

提高SCI期刊论文收录率的技巧与方法

MedSci指数透视SCI期刊大量秘密，发表文章前，你必需懂的

SCI期刊目前近万种，进进出出，曾经有影响因子的期刊超过10000种，可谓百花齐放。然而，据MedSci官方提供的MedSci指数数据显示，却不容乐观。整体来说，SCI期刊呈现行业集中化趋势。主要有以下几点：1 期刊集团化。象Nature原本仅仅是几本期刊而已，现在早已是国际上庞大的期刊出版集团，近年来大量发行新刊，这些新刊往往一经发布，即有很高的影响因子。同时通过旗下的OA期刊承接了大量优质稿源

MedSci指数进一步优化，进一步实时指数和年度指数

MedSci指数自从2009年推出以来(MedSci面向大中华区用户首推MedSci指数)，得到广大用户的重视与喜爱，它作为独立于影响因子之外的重要指标之一，可以认为是期刊选择的重要风向标(MedSci指数应用技巧：与影响因子配合使用)。 自从推出MedSci指数以来，一直关注各个期刊的指数变化趋势与特征，也为期刊发展提供重要的参考。 为了进一步完善MedSci指数体系，先前的

什么是MedSci指数？

据统计，单个中国科研工作者，在选择杂志时，往往在不到20种杂志内选择合适的杂志。为些，MedSci在相继推出影响因子查询，投稿经验分享，SCI杂志介绍以及主页链接同时，又推出重量级免费服务---MedSci热门指数，并与前面系统高度集成，四位一体，为科研工作者选择投稿杂志时提供科学化的评估指标。 MedSci热门指数，根

AACR出版集团旗下SCI杂志分析

AACR出版社 （American Association for Cancer Research）创立于1907年，由美国癌症研究协会（AACR）主办，聚焦癌症预防和治疗研究领域，旗下7本SCI期刊。其中Cancer Research以及Clinical Cancer Research都是肿瘤研究领域中的热门杂志，具有较高的影响力，对中国人相对友好，具有扎实数据的小伙伴们不妨试试哦！